Why Advicenne's Kidney Disease Drug Reverted To Standard EU Review

 
• By Ian Schofield
  
Kidney disease
Advicenne's kidney disease drug is now undergoing a standard EU review • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography